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The purpose of the study was to evaluate changes in general self-efficacy, health related quality of life (HRQoL), and stress
among patients with neuroendocrine tumors (NET) following a multidisciplinary educational intervention. Forty-one patients
were enrolled in this exploratory pilot study. A total of 37 patients completed the full 26-week intervention based on the principles
of self-efficacy. General self-efficacy was measured by the General Self-Efficacy Scale, HRQoL was measured with the SF-36, and
stress was measured with the Impact of Event Scale. Mixed effect models were used to evaluate changes in general self-efficacy,
mental and physical components of HRQoL, and stress adjusting for demographic and clinical variables. Results showed significant
improvements in patients’ general self-efficacy (𝛽 = 0.71; 𝑃 < 0.05), physical component scores of HRQoL (𝛽 = 3.09; 𝑃 < 0.01),
and stress (𝛽 = −2.10, 𝑃 = 0.008). Findings suggest that patients with NET have the capacity to improve their ability to cope with
their disease, problem-solve, improve their physical status, and reduce their stress following an educational intervention based on
the principles of self-efficacy.These preliminary data provide a basis for future randomized controlled trials to test interventions to
improve HRQoL for patients with NET.
1. Introduction
The incidence of the relatively slow growing and rare types
of neuroendocrine tumors (NET) is 5.3/100,000, and the
prevalence is 35/100,000 [1]. Neuroendocrine cells are dis-
tributed widely throughout the body, including the nervous
and endocrine systems.Neuroendocrine tumors produce and
secrete regulatory hormones, giving rise to symptoms includ-
ing fatigue, flushing, diarrhea, food intolerance, restlessness,
dyspnea, fluctuations in mood [2], and pain [3].
Symptoms varywidely andmay occur late in the course of
the disease, depending on the type of hormone affected and
the rate of secretion and localization, thus making diagnosis
challenging. In the majority of cases, a definitive diagnosis is
not made until after the tumor has metastasized [4]. Thus,
NET represents a clinical challenge in diagnosis, treatment,
and care. Palliative treatment includes biological agents, such
as somatostatin analogues, interferon, and embolization of
liver metastases, and frequently gives rise to side effects that
may be similar to the symptoms of NET [5, 6].
Stress is a common reaction to cancer [7–11] and may
influence patients’ adaptation to the disease [5]. Conse-
quently, stress can have a sustained impact on patients’
ability to function, which in turn may increase the risk of
reduced health related quality of life (HRQoL) [7–9, 12–16].
Patients with NET have demonstrated decreased HRQoL in
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previous studies [17–21]. Interventions enabling patients to
cope with stress and thus improving their HRQoL may be
a complementary treatment option. Norwegian legislation
[22] mandates that patients with chronic diseases have access
to information and education that contribute to coping
and maintenance of independence and functional ability.
Bodenheimer et al. have developed the Chronic Care Model
to guide interventions aimed at improving chronic illness
management [23]. The model includes elements such as self-
management support, which involves collaboratively helping
patients and their families acquire skills and confidence to
manage their chronic illness, providing self-management
tools and routinely assessing problems and accomplishments.
Core components of chronic care interventions could also
be based on the principles of self-efficacy to help motivate
patients to self-manage their symptoms and adopt new
skills and competencies. Different components of patient
education such as patient and family knowledge, provision
of emotional and psychosocial support, self-efficacy, coping
skills, and relaxation training have been shown to be effective
in reducing stress and improving HRQoL across settings and
disease conditions [13, 15, 16, 24–28].
Self-management interventions in general, and disease-
specific interventions in particular, have shown varying levels
of efficacy on outcomes such as physical health [29–31],
physical function [32], health status [33], general health [34],
disease-specific self-efficacy [35, 36], weight self-efficacy [31],
and perceived stress [29]. However, these studies may not
be comparable because of theoretical and methodological
differences. No studies have reported on educational inter-
ventions based on self-efficacy in patients with NET. Hence,
the purpose of the study was to evaluate changes in stress,
general self-efficacy, and HRQoL among patients with NET,
following an educational intervention based on the principles
of self-efficacy.
2. Methods
2.1. Design and Sample. A single-group pre/posttest design
was used. Measures were completed at three time points (T1–
T3): baseline, following phase 1 of the intervention (2 weeks),
and at the completion of the intervention (26 weeks). All
137 patients referred to three of the five Norwegian regional
university hospital NET centers (Bergen, Trondheim, and
Oslo) from September 2005 to December 2007 were invited
to participate. Inclusion criteria were ≥18 years of age, NET
diagnosis within the last 24 months, undergoing medical
treatment for NET, having tumors restricted to the gastroin-
testinal tract, and able to speak and read Norwegian. Those
who had previously completed an educational program,
were terminally ill, had undergone radical surgery, or were
suffering from cognitive or mental deficits were excluded.
The study was approved by the Regional Ethics Committee
in Health, Region II (South) of Norway and the Norwegian
Social Science Data Services. Written informed consent was
obtained. Patients received questionnaires by mail following
enrollment. Those who did not return the questionnaire
within two weeks received a reminder letter by mail. Forty-
one patients agreed to participate (response rate 30%),
37 returned the pretest questionnaire two weeks prior to
the start of the intervention (90%), and 29 (71%) patients
returned the questionnaire on completion of the 26-week
intervention program (see Figure 1).
2.2. The 26-Week Intervention. Bandura’s Social Cognitive
Theory focusing on self-efficacy has been the foundation for
successful interventions in previous research [37].
Self-efficacy is the belief in one’s competence to take on
difficult or novel tasks and to copewith adversity arising from
demanding situations [38]. Self-efficacy relates to actions and
control during specific situations and is outcome specific.
Self-efficacy is commonly understood as domain specific, in
that one can have more or less firm self-beliefs in different
domains or particular situations of functioning.
A general sense of self-efficacy, however, refers to a global
confidence in one’s coping ability across a wide range of
demanding or novel situations and reflects a person’s general
problem-solving ability. General self-efficacy aims at a broad
and stable sense of personal competence to deal effectively
with a variety of stressful situations over time [38]. Improving
a patient’s general self-efficacymay act as a basis for problem-
solving strategies.
General strategies for enhancing self-efficacy incorporate
the following: (1) mastery experience, which includes giving
positive feedback when patients have performed a desired
activity; (2) vicarious experience, or modeling others, gained
throughwatching someone else in a similar situationwho has
had success in performing activities; (3) verbal persuasion,
which involves encouraging patients to believe that they
have the ability to achieve their goals; and (4) strengthening
physical and psychological states, which includes teaching
patients about disease-specific knowledge and psycholog-
ical reactions to severe illness [39]. The multidisciplinary
intervention consisted of 10 sessions over a period of 26
weeks. The program included lectures, group discussions,
and individual telephone calls in two phases (Figure 1). The
intervention integrated both domain-specific and general
problem solving, such as dealing with symptoms and other
peoples’ reactions to severe disease, respectively.
2.2.1. Phase 1. Thefirst phase took place over four consecutive
days and included lectures and group discussions. Before-
hand, all patients participated in a 45-minute orientation ses-
sion to introduce them to the study protocols and goals and
the principles of general self-efficacy.This was followed by an
introductory session where the patients received a booklet
containing the intervention protocol. Lectures consisted of
one 45-minute didactic session on each of the four mornings
followed by a 60-minute group discussion in the afternoon.
The goals of the morning sessions were to improve the
patients’ knowledge of NET, side effects of medication and
treatment, and what to expect in follow-up sessions. In the
afternoon group discussions, the patients participated in
motivational training in self-efficacy enhancing strategies led
by the study nurse.Motivational training included training in
mastery techniques by empathetic guidance in goal setting,
writing goals, and discussing how best to achieve them based
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137 patients eligible for 
the intervention
41 patients accepted to 
participate
𝑇1 took place at 
baseline
96 patients declined to 
participate
2 patients did not receive 
intervention; 2 patients 
discontinued intervention
37 patients responded at baseline
37 patients responded
29 patients responded
Phase 1: 16 lessons and 4 
groups took place 2 weeks after 
baseline
𝑇2 took place 2 
weeks after onset of 
intervention
Phase 2: 6 group talks and 18 
individual calls took place and 
lasted 24 weeks
𝑇3 took place after 
26 weeks follow-up 
intervention after 
baseline
Figure 1: Flow diagram for the participants of the intervention and the time of test points.
on previous successful experiences. By specific and construc-
tive questioning on patient priorities the participants were
taught how to break down large goals into smaller, weekly
action plans that were measurable, realistic, and attainable.
Vicarious learning was modeled on other patients’ successful
self-care activities by encouraging patients to share positive
self-care solutions within the group. The nurse also taught
patients how tomutually encourage each other in self-efficacy
thoughts as well as supporting constructive alternatives in
setting goals if barriers were encountered. One strategy used
to strengthen patients’ physical and physiological status was
to improve their knowledge about NET and mental reactions
on severe disease. In addition, learning about the positive
outcomes of physical activity on health helped patients
understand that participation in physical activities was safe
and beneficial. Patients also learned about the trajectory of
their illness and how best to respond to symptoms and when
it was appropriate to contact their physician or nurse.
2.2.2. Phase 2. The second phase of the study lasted for
24 weeks and included six follow-up group discussions and
18 individual telephone calls, all conducted by six nurses
specializing in NET. Patients met at their regional hospital
for 90-minute group discussions every four weeks. Four to
six individuals took part in each group discussion. Weekly
telephone calls (45 minutes) were made between group
meetings.The nurses led motivation and training exercises to
assist the patients in achieving their goals by giving positive
feedback and focusing on individual strengths and successes
(Table 1).
To ensure adherence to the intervention, the principal
investigator trained the study nurses on the application of
self-efficacy principles during three 45-minutes sessions and
in additional booster sessions. Nurses also received a training
booklet to refer to as needed. A critical self-evaluation
was performed after every group session, by reflecting on
how the four principles of self-efficacy had been discussed
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Table 1: Description of the 26-week intervention.
Intervention topic (numbers ×minutes) Content Facilitated by
Phase 1 week 1
Introduction (1 × 45)
(i) Study protocol, information about goal setting and
information about principles of self-efficacy. The patients
received a booklet with the intervention protocol to take
home
(i) The principle
investigator
Lectures (16 × 45)
(i) Disease-specific knowledge
(ii) Psychological reactions on severe illness
(iii) Social rights
(iv) Physical activity
(v) Nutrition
(i) Physician
(ii) Psychologist
(iii) Social worker
(iv) Physiotherapist
(v) Nutritionists
Group sessions (4 × 60)
Discussions based on the principles of self-efficacy in order to
enhance problem-solving strategies
(i)Mastery experiences: utilize previous, optimistic, and
positive experiences and evaluate their written goals
(ii) Vicarious experiences: utilize significant other’s optimistic
and positive experiences in the coping process
(iii) Verbal persuasion: encouraged in believing that they
could achieve their goals and in sharing experiences as well
as supporting other’s coping strategies
(iv) Strengthening physical and psychological state: utilize
disease-specific knowledge and enable the patients to
recognize disease-specific symptoms and when to contact
health care for assistance
(i) Nurse
Phase 2 week 2–6
Group sessions (6 × 90) (i) Discussions based on the principles of self-efficacy in orderto enhance problem-solving strategies (i) Nurse
Individual telephone calls (18 × 30) (i) Individual support based on the principles of self-efficacy:follow up of weekly goals and reflective notes (i) Nurse
and supported. Reflections were then logged for follow-up
discussion with the principal investigator.
3. Measures
3.1. Background Characteristics. Sociodemographic variables
measured were gender, age, education level, marital status
(living with partner or not), employment status (employed or
not), and income (measured in Norwegian Kroner). Disease-
specific symptoms were listed, and patients were asked to
indicate how often they experienced each of them, measured
as never (0), occasionally (1), often (2), very often (3), and
most of the time (4). Comorbid conditions were measured
dichotomously (yes/no).
3.2. General Perceived Self-Efficacy. The General Perceived
Self-Efficacy Scale is a 10-item scale that measures general
self-efficacy. Each item is scored from 1 (not at all true) to 4
(completely true). The summary score ranges from 10 to 40,
with the highest score indicating high self-efficacy. The scale
has demonstrated validity and reliability across cultures [40].
Mean substitution was used to calculate the score when fewer
than 50% of item scores were missing.
3.3. Health Related Quality of Life. Health related quality of
life was measured by the SF-36. The eight SF-36 subscales
were transformed into standardized physical (PCS) andmen-
tal (MCS) component scores [41], using normative United
States (US) data. Both PCS and MCS component scores were
analyzed. A deviation of 10 points from the mean score
(50) represents a difference of one standard deviation in the
general US population.The scales and items of the SF-36 have
shown satisfactory reliability, validity, and responsiveness
to changes in health status [42] across a broad range of
patient populations [43]. Normative values for the SF-36 have
been published for the Norwegian population [43]. Mean
substitution was used to calculate the score for dimensions
when fewer than 50% of the scores weremissing, as suggested
in the SF-36 manual [44].
3.4. Impact of Event Scale. A modified version of the Impact
of Event Scale (IES)was used tomeasure current stress specif-
ically related to NET. Seven items assess intrusive thoughts,
which can be described as invasive ideas, images, feelings,
or bad dreams about cancer. Eight items assess avoidance
behaviors, which are described as consciously recognized
avoidance of certain ideas, feelings, or situations. Each item
is scored on a 6-point scale from 0 (never) to 5 (often). The
total score ranges from 0 to 75. Higher scores indicate higher
stress. The IES questionnaire has been found to be valid and
reliable [45]. All patients except one answered all items on the
scale. Mean substitution was calculated (mean of 7 items) for
the three items that were missing for this person.
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3.5. Statistical Analyses. Descriptive statistics were used to
assess participant characteristics (Table 2) and outcomemea-
sures (stress, general self-efficacy, PCS, and MCS) (Table 3).
Mixed effect models with unstructured covariance were
applied to evaluate overall change in the four outcome
measures from T1 to T3 and change across individuals [46].
This analysis does not require list-wise deletion of missing
data. These analyses enabled estimation of average within-
patient change over time on our primary outcome measures
and the rate of change across patients. We adjusted for
age, gender, symptoms, and comorbidity in all analyses. For
each of the explanatory variables, the effects of interaction
with time were evaluated separately. Gender, baseline age,
and comorbidity were held constant across time and were
considered fixed predictors in the models. Changes in the
number and frequency of symptoms over the three time
points were included as time variables. Given the small
sample size, we used time (T1, T2, and T3) as a linear
variable. Because the average change in cancer-related stress
deviated from linearity, we also ran the model using time as
a categorical variable, which gave similar results.
Effect size (ES) for changes in stress, general self-efficacy,
and HRQoL was calculated by computing the differences in
mean scores divided by the pooled standard deviation to
estimate and interpret clinically meaningful changes [47].
Effect sizes of 0.20 to 0.49 were regarded as small, of 0.50 to
0.80 as moderate, and greater than 0.80 as large [47].
4. Results
4.1. Background Characteristics. The demographic and clin-
ical characteristics of the sample (𝑛 = 37) are described
in Table 2. Of these, 37 completed the intervention (see
Figure 1). Their ages ranged from 36 to 80 years, with almost
equal numbers of women (𝑛 = 17) and men (𝑛 = 20). The
majority were currently married or cohabitating (76%). The
participants were relatively well educated, with 73% having
a high school education or higher. In terms of employment,
35% were currently working, 56% were retired, and the
remaining 9% did not respond to the question. The average
income was high (542 000 NOK). Thirty-six patients (89%)
had been diagnosed with NET more than 6 months before
enrollment in the study (mean = 13 months). The most fre-
quently reported symptom (89%) was food intolerance, and
flushing and restlessness were the least reported symptoms
(19%), while 22% had comorbid conditions such as arthritis,
breast cancer, and myocardial infarction. A comparison of
demographic and clinical characteristics between those who
completed the intervention and those who withdrew showed
no significant differences in age (𝑃 = 0.90) or gender (𝑃 =
0.51).
4.2. Changes in Stress, General Self-Efficacy, and Health
Related Quality of Life. Mean scores and effect sizes for
measures from T1 to T3 are shown in Table 3. The estimated
ES was 0.16 for stress, 0.32 for general self-efficacy, and 0.37
for PCS. There was a statistically significant improvement
in stress following the intervention (𝛽 = –2.10; 𝑃 = 0.008)
after adjusting for gender, age, comorbidities, and symptoms.
Table 2: Sample characteristics at time of inclusion (𝑛 = 37).
Background variables 𝑁 (%) Mean (range)
Age mean 30 (81) 60 (36–80)
Missing 7 (19)
Income NOK 29 (78) 542a (100a–4500a)
Missing 3 (8)
Disease duration (months) 29 (78) 13 (1–24)
Missing 2 (5)
Gender
Male 17 (46)
Female 20 (54)
Marital status
Single, divorced, widowed 9 (24)
Married, cohabitation 28 (76)
Education
Primary< 10 years 10 (27)
High school 10–13 years 11 (30)
Secondary> 13 years 16 (43)
Working situation
Working 13 (35)
Retired 21 (56)
Missing 3 (9)
Symptoms frequently
Diarrhea 13 (35)
Fatigue 13 (35)
Nutrition intolerance 33 (89)
Flushing 7 (19)
Restlessness 7 (19)
Fluctuating mood 11 (30)
Others 𝑛 (%) 3 (9)
Comorbid conditions (≥1) 8 (22)
NOK: Norwegian currency (kroner).
a: 000.
Levels of stress were higher for those with more than one
symptom (𝛽 = 7.96; 𝑃 = 0.001). General self-efficacy showed
a small but statistically significant improvement over time
(𝛽 = 0.71; 𝑃 < 0.05). The PCS component of HRQoL
was significantly improved (𝛽 = 3.09; 𝑃 < 0.01) after
adjusting for gender, age, comorbidities, and symptoms. The
presence of comorbid conditions and/or more than one
symptom was associated with a lower PCS. There was an
interaction between PCS and gender, with women showing
less improvement in PCS than men (𝛽 = –2.77; 𝑃 < 0.05)
(Table 4).
5. Discussion
This is the first study focusing on the evaluation of an
educational intervention based on the principles of self-
efficacy in patients with NET. Patients participated in an
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Table 3: Pretest and posttestmean scores, standard deviation (SD), and effect size for scores fromT1 to T3 formental and physical component
scores, stress, and general self-efficacy in patients with neuroendocrine tumors (T1, 𝑛 = 36-37; T2, 𝑛 = 37; T3, 𝑛 = 29-30).
Pretest T1
Mean (SD)
(𝑛 = 36)
Posttest T2
Mean (SD)
(𝑛 = 37)
Posttest T3
Mean (SD)
(𝑛 = 29)
Difference from
T1 to T3
Effect Size
Mental component score 43.3 (9.3) 43.9 (10.7) 43.7 (12.1) 0.03
Physical component scores 42.1 (10.1) 44.8 (8.5) 45.7 (9.1) 0.37
Stress 26.5 (13.6) 23.3 (14.3) 24.2 (14.8)a 0.16
General self-efficacy 31.2 (3.2)b 32.00 (3.8) 32.3 (3.7)c 0.32
a, c: 𝑛 = 30; b: 𝑛 = 37.
Scores: cancer related stress: 0–75; general self-efficacy: 10–40; mental and physical component scores: mean score: 50. Higher scores indicate better mental
and physical component scores, general self-efficacy, and worse cancer related stress.
Abbreviations: T1: test time 1; T2: test time 2; T3: test time 3.
Table 4: Adjusted mixed-effect models for longitudinal mean changes in stress, general self-efficacy, and mental and physical component
scores (𝑛 = 37).
Variables
Step 2 explanatory
model: stress
estimate (SE)
Step 2 explanatory
model: general
self-efficacy
estimate (SE)
Step 2 explanatory
model: mental
component scores
estimate (SE)
Step 2 explanatory
model: physical
component scores
estimate (SE)
Intercept (baseline) 22.9 (9.1) 33.78 (2.56) 43.08 (1.50) 55.08 (5.33)
Change over time −2.10 (0.78)b 0.71 (0.33)a 0.36 (0.96) 3.09 (0.91)b
Gender (women) −2.73 (3.96) −1.17 (1.03) 1.65 (2.87)
Time ∗ gender −2.77 (1.29)a
Age −0.02 (0.01) −0.03 (0.64) − 0.13 (0.08)
Comorbidity (Yes) 1.85 (4.34) 1.06 (1.22) −8.47 (2.45)b
Symptoms (≥1) 7.96 (2.3)b −0.31 (0.64) −4.86 (1.58)b
Age is based on the mean of the sample.
Significance level: a: 𝑃 < 0.05; b: 𝑃 < 0.01.
Abbreviations: SE: standard error of the mean.
extensive education program over 26 weeks that focused
on problem-solving strategies in relation to living with the
diagnosis of NET. Our study found significant improvements
in general self-efficacy, physical HRQoL, and stress following
the intervention. The improvements in PCS and general
self-efficacy were small but may be of clinical importance.
The clinical relevance of the improvement in stress is more
uncertain. In social cognitive theory, the concept of self-
efficacy represents a person’s judgment about her/his ability to
overcome barriers to achieve change [37]. Improved levels of
general self-efficacy may indicate that a person has enhanced
competence in problem-solving strategies and hence is able
to tackle demanding situations such as stress.
NET is one of several cancer diagnose, and it is reasonable
to use cancer studies in general as a comparison group for
our results. Systematic reviews of intervention studies in
which patients acquired new skills and gained confidence
to manage their disease show various effects with regard to
outcomes such as stress, self-efficacy, and HRQoL [13, 15,
16, 28]. For instance, findings from a literature review of
randomized controlled trials (RCT) byMcGregor andAntoni
demonstrate reduced levels of stress following cognitive
behavioral interventions in women treated for breast cancer
[11], similar to results from the present study. In a RCT
using individual psychosocial support based on techniques
derived from cognitive behavioral therapy in women with
breast cancer (𝑛 = 425), stress (measured by the intrusion
subscale of the Impact of Event Scale) was reduced following
the intervention [48]. In contrast, Chan et al. conducted
a RCT that included a psychoeducational intervention in
women with gynecologic malignancy (𝑛 = 155). The in-
tervention was aimed at helping patients understand the
link between thoughts, emotions, and physical well being.
Findings revealed no improvements in stress as measured by
the Impact of Event Scale [25].
With regard to self-efficacy and in contrast to the present
study, Chan et al. also found no improvements in general
self-efficacy following a psychoeducational intervention in
women with gynecologic malignancy (𝑛 = 155) [25]. Tama-
gawa et al. [28] summarized the benefits from psychosocial
interventions in oncology: the types of interventions were
as follows: cognitive-behavioral stress management cognitive
behavioral therapy; expressive writing, support group alone;
psychoeducation, support group plus psychoeducation; psy-
choeducation and life style and coping training; individual
supportive counseling; a booklet including self-management
skills and stories of other patients’ experiences; and a booklet
for treatment decision making. The results indicated that
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those with low levels of self-efficacy initially benefited from
psychosocial interventions, while those with higher levels
of self-efficacy at baseline did not [28]. Similar to our
findings, educational interventions have led to improvements
in HRQoL in other cancer populations. In a RCT of two
interventions, one based on education only, and the other
based on education and group discussion, men (𝑛 = 279)
with prostate cancer demonstrated significant improvements
in PCS in the education-plus-discussion group [30].
Doorenbos et al. showed that physical functionmeasured
by the SF-36 improves significantly in individuals with solid
tumor cancer (𝑛 = 237) following an intervention based
on self-care management information, counseling and sup-
port, and problem-solving and communication skills derived
from cognitive behavioral theory [32]. However, Chan et al.
found no improvement in cancer-specific physical HRQoL
following a psycho-educational and cognitive intervention in
women with gynecologic malignancy (𝑛 = 155) [25].
In the present study, men had a significantly larger
change in PCS than women. Men’s lower baseline scores for
PCS may explain this difference, because men had greater
potential for improving their PCS. Consistent with earlier
research [32], comorbid conditions were related to reduced
physical function. Despite this finding, research has shown
that interventions based on principles of self-efficacy have
positive effects on those at greater risk of lower physical
functioning [32].
Symptoms such as diarrhea or dyspnea may alter the
physical activities of patients with NET. Consistent with
research in individuals with solid tumor cancers [32] andmen
being treated for prostate cancer [49], findings from this study
indicated that frequent symptoms were associated with lower
PCS. It is possible that patients who experience symptoms
more frequently may gain greater benefit from psychosocial
interventions than those who are less troubled by symptoms
[28].
Since self-efficacy is behavior specific and not “general,”
the items included on the General Self-Efficacy Scale were
reviewed. They relate to problem solving and problem man-
agement. The scale might more appropriately be named
“Problem Management Self-Efficacy.” These are very impor-
tant behaviors for peoplewith chronic illnesses to learn and in
which to become confident in doing.The education program
developed for the patients in this study included content
and skills on problem solving and problem management.
Therefore, the positive changes in what is called “general self-
efficacy” might be “problemmanagement self-efficacy.” Since
this is an ongoing discussion, we are mentioning it here to
informour readers.Thiswas the toolwe used in the study, and
we did achieve significant improvement. Further research
related to clarifying the underlying dimensions of the scale
should be undertaken.
In the present study, the small sample size is a limitation.
The majority of patients who were eligible for the study
declined to participate. The fact that the patients were
geographically dispersed also limited their participation in
the intervention. The single group design was unavoidable
because of the small number of identifiable patients withNET
in Norway. However, the significant findings indicate that
the sample was large enough to detect significance where
it existed. Furthermore, due to the lack of control group
spontaneous remission is an evident rival hypothesis for our
findings. It can be expected that without any intervention,
patients will adapt to their situation, stress will decrease,
and their general self-efficacy and HRQoL will increase over
time. Therefore, the assertions about what has been proven
in this study should be verified in a satisfactory powered
and controlled trial. Finally, the intervention was long and
somewhat complicated, and it is not possible to determine if
a more streamlined intervention would be efficacious. Web-
based interventions may aid in overcoming this limitation,
make it possible to include people living in rural areas, and
may also be more cost effective.
Despite limitations, the study was feasible and demon-
strated that patients with NET show improvements in func-
tioning following a self-efficacy-based educational interven-
tion.
The findings have implications for oncology nursing.
As the intervention was time consuming for the research
team, it is possible that part of the intervention could be
integrated into discharge education. Future research on stress,
self-efficacy, and HRQoL in patients with NET may use
cognitive theory as a basis for a psychosocial intervention.We
demonstrated that using principles of self-efficacy to facilitate
mastery of self-care activities and symptom management is
feasible in patients with NET. Interventions directed towards
problems caused by challenges that are specific to NET could
be a focus of future research. Focusing on behavior-specific
self-efficacy, NET-related stress, and NET-related HRQoL
may add knowledge about specific problems in order to
achieve reduced levels of stress, so that patients become
confident in handling stressful situations and undertaking
activities. In addition, an initial assessment of patients’ social
support and behavior could be used to identify and target
vulnerable patients.
6. Conclusion
In this pilot study, we found decreased stress and enhanced
general self-efficacy and PCS following the educational inter-
vention in patients with NET. Learning about the disease
and engagement in strategies to enhance self-efficacy may
strengthen patients problem solving. Thus, the patients may
have overcome barriers to achieve change and are able to
tackle demanding situations such as stress. However, further
research using experimental design is needed to evaluate
effects of such an intervention.
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